S'abonner

The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study - 27/09/17

Doi : 10.1016/j.ajog.2017.02.037 
Roberto Romero, MD, DMedSci a, b, c, d, , Offer Erez, MD a, e, Eli Maymon, MD a, e, Piya Chaemsaithong, MD a, e, Zhonghui Xu, MSc a, Percy Pacora, MD a, e, Tinnakorn Chaiworapongsa, MD a, e, Bogdan Done, PhD a, Sonia S. Hassan, MD a, e, Adi L. Tarca, PhD a, e,
a Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, and Detroit, MI 
b Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 
c Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI 
d Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 
e Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI 

Corresponding authors: Roberto Romero, MD, DMedSci.∗∗Adi L. Tarca,

Abstract

Objective

Pregnancy is accompanied by dramatic physiological changes in maternal plasma proteins. Characterization of the maternal plasma proteome in normal pregnancy is an essential step for understanding changes to predict pregnancy outcome. The objective of this study was to describe maternal plasma proteins that change in abundance with advancing gestational age and determine biological processes that are perturbed in normal pregnancy.

Study Design

A longitudinal study included 43 normal pregnancies that had a term delivery of an infant who was appropriate for gestational age without maternal or neonatal complications. For each pregnancy, 3 to 6 maternal plasma samples (median, 5) were profiled to measure the abundance of 1125 proteins using multiplex assays. Linear mixed-effects models with polynomial splines were used to model protein abundance as a function of gestational age, and the significance of the association was inferred via likelihood ratio tests. Proteins considered to be significantly changed were defined as having the following: (1) >1.5-fold change between 8 and 40 weeks of gestation; and (2) a false discovery rate–adjusted value of P < .1. Gene ontology enrichment analysis was used to identify biological processes overrepresented among the proteins that changed with advancing gestation.

Results

The following results were found: (1) Ten percent (112 of 1125) of the profiled proteins changed in abundance as a function of gestational age; (2) of the 1125 proteins analyzed, glypican-3, sialic acid-binding immunoglobulin-type lectin-6, placental growth factor, C-C motif-28, carbonic anhydrase 6, prolactin, interleukin-1 receptor 4, dual-specificity mitogen-activated protein kinase 4, and pregnancy-associated plasma protein-A had more than a 5-fold change in abundance across gestation (these 9 proteins are known to be involved in a wide range of both physiological and pathological processes, such as growth regulation, embryogenesis, angiogenesis immunoregulation, inflammation etc); and (3) biological processes associated with protein changes in normal pregnancy included defense response, defense response to bacteria, proteolysis, and leukocyte migration (false discovery rate, 10%).

Conclusion

The plasma proteome of normal pregnancy demonstrates dramatic changes in both the magnitude of changes and the fraction of the proteins involved. Such information is important to understand the physiology of pregnancy and the development of biomarkers to differentiate normal vs abnormal pregnancy and determine the response to interventions.

Le texte complet de cet article est disponible en PDF.

Key words : aptamer, biomarker, carbonic anhydrase-6, C-C motif-28, dual-specificity mitogen-activated protein kinase kinase-4, glypican-3, high-throughput biology, interleukin-1 receptor 4, placental growth factor, pregnancy-associated plasma protein A, prolactin, proteins, sialic acid-binding immunoglobulin-type lectin-6


Plan


 The authors report no conflict of interest.
 This study was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, and, in part, with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN275201300006C.
 Cite this article as: Romero R, Erez O, Maymon E, et al. The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study. Am J Obstet Gynecol 2017;217:67.e1-21.


© 2017  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 217 - N° 1

P. 67.e1-67.e21 - juillet 2017 Retour au numéro
Article précédent Article précédent
  • Single versus double-layer uterine closure at cesarean: impact on lower uterine segment thickness at next pregnancy
  • Chantale Vachon-Marceau, Suzanne Demers, Emmanuel Bujold, Stephanie Roberge, Robert J. Gauthier, Jean-Charles Pasquier, Mario Girard, Nils Chaillet, Michel Boulvain, Nicole Jastrow
| Article suivant Article suivant
  • Sonographic prediction of outcome of vacuum deliveries: a multicenter, prospective cohort study
  • Birgitte H. Kahrs, Sana Usman, Tullio Ghi, Aly Youssef, Erik A. Torkildsen, Elsa Lindtjørn, Tilde B. Østborg, Sigurlaug Benediktsdottir, Lis Brooks, Lotte Harmsen, Pål R. Romundstad, Kjell Å. Salvesen, Christoph C. Lees, Torbjørn M. Eggebø

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.